2-(3,4-Dimethylphenyl)-1,3,2-dioxaborinane, 95.0%, 250mg

2-Bromo-N-(2-methylphenyl)propanamide, 95.0%, 100mg

4-Acetyl-2-(2,6-dimethylphenoxy) pyridine, 95%, 1g

4-Bromopyrrole-2-carboxylic acid, 95.0%, 5g

3-Oxo-N-(4-trifluoromethylphenyl)butyramide>98.0%(HPLC)(N)1g

4,6-Diaminobenzene-1,3-diol dihydrochloride, 97.0%, 25g

3,5-Dibromo-2,6-dimethoxypyridine, 95.0%, 5g

1-Bromo-4-(trimethylsilyl)benzene>97.0%(GC)25g

Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-, 97%, 1g

2-trifluoromethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole, 95.0%, 250mg

3-Fluoro-2-hydroxybenzamide, 97%, 5g

2-adamantanone, min 99%, for synthesis, 25 g, glass packaging

5-(Chloromethyl)-3-(2-furyl)-1,2,4-oxadiazole, 95.0%, 1g